All posts by Russell Phillips

Type 2 Diabetes Raises Alzheimer’s Disease Risk

Type 2 diabetes and Alzheimer’s disease are two distressing, but increasingly common, diseases seen in our aging population. At some point in the future, they may well overwhelm the healthcare system. Alzheimer’s and type 2 diabetes are linked physically as well as fiscally. A study published in the August 25, 2010, edition of the medical … Continue reading Type 2 Diabetes Raises Alzheimer’s Disease Risk

Coconut Oil Could Reduce The Symptoms Of Type 2 Diabetes

A diet including coconut oil, a medium chain fatty acid (MCFA), helps combat insulin resistance. Insulin resistance is the inability of cells to respond to insulin and take in glucose for energy. The pancreas tries to compensate for insulin resistance by producing even more insulin, but eventually glucose accumulates in the bloodstream. Over time, insulin … Continue reading Coconut Oil Could Reduce The Symptoms Of Type 2 Diabetes

Environmental Factors In Diabetes

Both genetic components and environmental factors play a role in most chronic diseases, including type 2 diabetes. In the same way that researchers use a Genome-Wide Association Study (GWAS) to evaluate the role of genetic factors in disease, scientists at Stanford University have used an Environmental-Wide Association Study (EWAS) to evaluate environmental factors on diabetes. … Continue reading Environmental Factors In Diabetes

FDA’s Bad Ad Program

The Food and Drug Administration (FDA) has launched a “Bad Ad Program,” an outreach effort aimed at educating healthcare providers and urging them to report misleading drug advertisements. The Division of Drug Marketing, Advertising, and Communications (DDMAC), in the FDA’s Center for Drug Evaluation and Research, administers the program. The program will help healthcare providers … Continue reading FDA’s Bad Ad Program

FDA Launches Initiative to Reduce Infusion Pump Risks

Last week the U.S. Food and Drug Administration announced an initiative to evaluate safety problems that may occur with external infusion pumps.  These devices are used to deliver fluids or medications to patients in a controlled manner. Insulin pumps, for example, release insulin into the body at a controlled rate to compensate for a lack … Continue reading FDA Launches Initiative to Reduce Infusion Pump Risks

Smart Insulin

A team of researchers from Case Western University published an article revealing their invention of a “smart” insulin molecule that binds considerably less to cancer receptors and self-assembles under the skin. To provide a slow-release form of insulin, the compound self-assembles under the skin by “stapling” itself together with zinc ions. Zinc staples connect the … Continue reading Smart Insulin